{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:31:54Z","timestamp":1791937914369,"version":"4.3.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ijrobp.2020.01.017","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T11:22:21Z","timestamp":1580124141000},"page":"48-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Stereotactic Body Radiation Therapy of Adrenal Metastases: A Pooled Meta-Analysis and Systematic Review of 39 Studies with 1006 Patients"],"prefix":"10.1016","volume":"107","author":[{"given":"William C.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe D.","family":"Baal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulysis","family":"Baal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Boreta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E.","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Raleigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2020.01.017_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.eursup.2017.09.005","article-title":"Oligometastases in genitourinary tumors: Recent insights and future molecular diagnostic approach","volume":"16","author":"Conti","year":"2017","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib2","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1200\/JCO.2012.45.9651","article-title":"Extracranial oligometastases: A subset of metastases curable with stereotactic radiotherapy","volume":"31","author":"Corbin","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lungcan.2015.11.015","article-title":"The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer","volume":"92","author":"Guerrero","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib4","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41467-018-04278-6","article-title":"Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis","volume":"9","author":"Pitroda","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/cncr.11084","article-title":"Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases","volume":"97","author":"Wood","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib6","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1200\/JCO.2007.14.2091","article-title":"Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: A systematic review and pooled analysis","volume":"26","author":"Tanvetyanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib7","doi-asserted-by":"crossref","first-page":"E501","DOI":"10.1016\/j.ijrobp.2019.06.1316","article-title":"Stereotactic ablative radiotherapy outcomes for metastatic adrenal gland tumors in lung cancer based on histology subtype and molecular profile","volume":"105","author":"Chiang","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JCO.2019.37.4_suppl.447","article-title":"Local control following stereotactic body radiotherapy to adrenal oligometastases","volume":"37","author":"Figura","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib9","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0167-8140(19)30492-X","article-title":"OC-0072 Clinical outcomes of stereotactic MR-guided adaptive radiation therapy for adrenal oligometastases","volume":"133","author":"Cobussen","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib10","doi-asserted-by":"crossref","first-page":"S876","DOI":"10.1016\/S0167-8140(19)32045-6","article-title":"EP-1625 Patterns-of-care and outcome-analysis of the stereotactic body RT (SBRT) of adrenal-glandmetastases","volume":"133","author":"Voglhuber","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib11","doi-asserted-by":"crossref","first-page":"E565","DOI":"10.1016\/j.ijrobp.2019.06.1223","article-title":"Fractionated stereotactic body radiation therapy (SBRT) provides excellent local control for peri-adrenal and adrenal metastases","volume":"105","author":"Everett","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13566-012-0037-8","article-title":"Stereotactic body radiotherapy for adrenal metastases from lung cancer","volume":"1","author":"Guiou","year":"2012","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib13","doi-asserted-by":"crossref","first-page":"S377","DOI":"10.1016\/j.ijrobp.2010.07.890","article-title":"SBRT for adrenal gland metastasis using single dose vs. fractionated dose regimen","volume":"78","author":"Levin","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib14","doi-asserted-by":"crossref","first-page":"S493","DOI":"10.1016\/S0167-8140(12)71632-8","article-title":"EP-1299 image guided stereotactic body radiotherapy for adrenal metastases","volume":"103","author":"Engin","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/COC.0b013e3182569189","article-title":"Stereotactic body radiotherapy in the treatment of adrenal metastases","volume":"36","author":"Ahmed","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/COC.0b013e3181dbb727","article-title":"Role of radiotherapy for local control of asymptomatic adrenal metastasis from lung cancer","volume":"34","author":"Oshiro","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib17","doi-asserted-by":"crossref","first-page":"S907","DOI":"10.1016\/j.ijrobp.2014.05.2577","article-title":"Local control and role of fractionation in stereotactic body radiation therapy for adrenal gland metastasis","volume":"90","author":"Rochefort","year":"2014","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib18","doi-asserted-by":"crossref","first-page":"S326","DOI":"10.1016\/j.ijrobp.2014.05.1079","article-title":"Outcome after SBRT of adrenal gland metastases: A multicenter retrospective analysis of 60 adrenal metastases","volume":"90","author":"Lindberg","year":"2014","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib19","article-title":"Treating adrenal tumors in 26 patients with CyberKnife: A mono-institutional experience","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib20","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/S0167-8140(15)30885-9","article-title":"PO-0767: Clinical experience in the treatment of adrenal metastases with stereotactic body radiation therapy (SBRT)","volume":"111","author":"Anchuelo Latorre","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fonc.2015.00185","article-title":"A retrospective review of CyberKnife stereotactic body radiotherapy for adrenal tumors (primary and metastatic): Winthrop University Hospital experience","volume":"5","author":"Desai","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib22","doi-asserted-by":"crossref","first-page":"E273","DOI":"10.1016\/j.ijrobp.2016.06.1311","article-title":"Outcomes and toxicity for treatment of adrenal metastases with radiation therapy","volume":"96","author":"Wang","year":"2016","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib23","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/j.prro.2016.09.005","article-title":"Stereotactic ablative radiotherapy for adrenal gland metastases: factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity","volume":"7","author":"Chance","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib24","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1016\/j.ijrobp.2018.07.358","article-title":"Stereotactic body radiation therapy (SBRT) for adrenal metastasis provides more than local control","volume":"102","author":"Al-Assaf","year":"2018","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818809983","article-title":"Real-time tumor-tracking radiotherapy and general stereotactic body radiotherapy for adrenal metastasis in patients with oligometastasis","volume":"17","author":"Katoh","year":"2018","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib26","doi-asserted-by":"crossref","first-page":"E472","DOI":"10.1016\/j.ijrobp.2017.06.1731","article-title":"Response of oligometastatic non-small cell lung cancer to the adrenal gland treated with stereotactic body radiosurgery","volume":"99","author":"Lederman","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib27","doi-asserted-by":"crossref","first-page":"S872","DOI":"10.1016\/S0167-8140(19)32039-0","article-title":"EP-1619 SBRT and the treatment of adrenal gland metastasis","volume":"133","author":"Georgiev","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib28","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1016\/S0167-8140(18)31081-8","article-title":"PO-0771: Fractionated SBRT for adrenal metastasis: contributing to local tumor control with modest toxicity","volume":"127","author":"Knippen","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib29","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.4103\/jcrt.JCRT_655_16","article-title":"Single institution experience treating adrenal metastases with stereotactic body radiation therapy","volume":"15","author":"Shah","year":"2019","journal-title":"J\u00a0Cancer Res Ther"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib30","doi-asserted-by":"crossref","unstructured":"Scouarnec C, Pasquier D, Luu J, et\u00a0al. Usefulness of stereotactic body radiation therapy for treatment of adrenal gland metastases [e-pub ahead of print]. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2019.00732, Accessed November 1, 2019.","DOI":"10.3389\/fonc.2019.00732"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib31","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3109\/0284186X.2011.652738","article-title":"Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: A retrospective analysis of 34 patients","volume":"51","author":"Scorsetti","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5301\/tj.5000222","article-title":"Evaluation of stereotactic body radiation therapy in the management of adrenal metastases from non-small cell lung cancer","volume":"101","author":"Gamsiz","year":"2015","journal-title":"Tumori"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib33","article-title":"Robotic radiosurgery for adrenal gland metastases","volume":"9","author":"Haidenberger","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib34","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.21873\/anticanres.12788","article-title":"Treatment of adrenal metastases with conventional or hypofractionated image guided radiation therapy\u00a0\u2013 patterns and outcomes","volume":"38","author":"Buergy","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13014-018-1152-5","article-title":"Short-term outcomes and clinical efficacy\u00a0of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer","volume":"13","author":"Zhao","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4143\/crt.2016.057","article-title":"Minimally invasive stereotactical radio-ablation of adrenal metastases as an alternative to surgery","volume":"49","author":"Franzese","year":"2017","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.adro.2017.07.011","article-title":"SBRT to adrenal metastases provides high local control with minimal toxicity","volume":"2","author":"Plichta","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib38","first-page":"5285","article-title":"Robot-assisted extracranial stereotactic radiotherapy of adrenal metastases in oligometastatic nonsmall cell lung cancer","volume":"37","author":"Celik","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.adro.2018.05.006","article-title":"Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity","volume":"3","author":"Toesca","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijrobp.2008.10.079","article-title":"Stereotactic body radiotherapy for treatment of adrenal metastases","volume":"75","author":"Chawla","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00066-011-2192-z","article-title":"Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer","volume":"187","author":"Holy","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2010.11.060","article-title":"Stereotactic radiotherapy for adrenal gland metastases: University of Florence experience","volume":"82","author":"Casamassima","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2217\/fon.10.165","article-title":"Stereotactic body radiation therapy for adrenal metastases: A retrospective review of a noninvasive therapeutic strategy","volume":"7","author":"Torok","year":"2011","journal-title":"Future Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7785\/tcrt.2012.500320","article-title":"Stereotactic body radiation therapy for curative treatment of adrenal metastases","volume":"12","author":"Rudra","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib45","first-page":"9","article-title":"Adrenal insufficiency in bilateral adrenal metastasis implemented SBRT","volume":"2","author":"Cihan","year":"2018","journal-title":"J Radiol Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib46","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3109\/0284186X.2012.671957","article-title":"Serious gastric ulcer event after stereotactic body radiotherapy (SBRT) delivered with concomitant vinorelbine in a patient with left adrenal metastasis of lung cancer","volume":"51","author":"Onishi","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib47","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.rpor.2015.05.009","article-title":"SBRT: A viable option for treating adrenal gland metastases","volume":"20","author":"Ippolito","year":"2015","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib48","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib49","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1-Update and clarification: From the RECIST committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib50","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0","year":"2009"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib51","series-title":"R: A Language and Environment for Statistical Computing","year":"2016"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib52","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.ijrobp.2016.04.016","article-title":"Comparison of the effectiveness of radiofrequency ablation with stereotactic body radiation therapy in inoperable stage I non-small cell lung cancer: A systemic review and pooled analysis","volume":"95","author":"Bi","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib53","doi-asserted-by":"crossref","unstructured":"Theelen WSME, Peulen HMU, Lalezari F, et\u00a0al. Effect of pembrolizumab after stereotactic body radiotherapy vs pembrolizumab alone on tumor response in patients with advanced non-small cell lung cancer: Results of the PEMBRO-RT phase 2 randomized clinical trial [e-pub ahead of print]. JAMA Oncol. https:\/\/doi.org\/10.1001\/jamaoncol.2019.1478. Accessed November 1, 2019.","DOI":"10.1001\/jamaoncol.2019.1478"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib54","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41416-018-0281-9","article-title":"A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours","volume":"119","author":"Maity","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib55","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.2017.76.2229","article-title":"Safety and clinical activity of pembrolizumab and multisite stereotactic body radiotherapy in patients with advanced solid tumors","volume":"36","author":"Luke","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib56","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1097\/JTO.0b013e318074de34","article-title":"Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study","volume":"2","author":"Onishi","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib57","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00432-014-1833-x","article-title":"Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer","volume":"141","author":"Scorsetti","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib58","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Schefter","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib59","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1200\/JCO.2014.56.7412","article-title":"Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer","volume":"32","author":"Iyengar","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib60","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/annonc\/mdu370","article-title":"Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients","volume":"25","author":"Collen","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib61","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS1117","article-title":"NRG-BR002: A phase IIR\/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and\/or surgical ablation for newly oligometastatic breast cancer (NCT02364557)","volume":"37","author":"Chmura","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib62","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020690","article-title":"Study protocol for the SARON trial: A multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer","volume":"8","author":"Conibear","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib63","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.01.017_bib64","first-page":"3","article-title":"Stereotactic body radiation therapy (SBRT) for adrenal metastases","volume":"4","author":"Francis","year":"2015","journal-title":"J Radiat Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620300766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620300766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:47:25Z","timestamp":1759744045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301620300766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0360301620300766"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.01.017","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic Body Radiation Therapy of Adrenal Metastases: A Pooled Meta-Analysis and Systematic Review of 39 Studies with 1006 Patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}